Reuters logo
BRIEF-Insys Therapeutics down 19.3 percent premarket after subpoena
December 13, 2013 / 1:35 PM / in 4 years

BRIEF-Insys Therapeutics down 19.3 percent premarket after subpoena

NEW YORK, Dec 13 (Reuters) - Insys Therapeutics Inc : * Down 19.3 percent premarket after subpoena from Office of Inspector General of the Department of Health and Human Services

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below